EIDOS -- Video Interview with Mike McGarvey, Chief Executive
March 04, 2004 03:22 ET
|
Cantos
LONDON, March 04, 2004 (PRIMEZONE) -- EIDOS: Interim results and IO Interactive acquisition
Indepth interview available now on www.cantos.com with Mike McGarvey, Chief Executive, Eidos (LSE:EID)...
NUMICO -- video interviews with CEO and CFO
March 04, 2004 03:12 ET
|
Cantos
ZOETERMEER, The Netherlands, March 4, 2004 (PRIMEZONE) -- 2003 results and future targets. Log on to www.cantos.com for indepth interviews with the Chief Executive and Chief Financial Officer of...
Notification to the Oslo Stock Exchange re purchase of own shares
March 04, 2004 03:01 ET
|
Telenor
Telenor`s largest shareholder, the Kingdom of Norway, has committed to participate in the buyback by cancelling a proportionate part of its shares, leaving their ownership unchanged. The compensation...
Melding til Oslo Børs vedr. kjøp av egne aksjer
March 04, 2004 02:59 ET
|
Telenor
Staten har, som Telenors største aksjeeier, forpliktet seg til å delta i tilbakekjøpet ved å kansellere en proporsjonal del av sine aksjer slik at statens eierandel forblir uendret....
Acceptance from the Corporate Assembly
March 04, 2004 02:42 ET
|
Orkla ASA
For release content, please refer to the attachment....
Bedriftsforsamlingens godkjennelse
March 04, 2004 02:39 ET
|
Orkla ASA
For release content, please refer to the attachment....
Proha Plc Financial Statements January 1 -- December 31, 2003
March 04, 2004 02:22 ET
|
Proha OYJ
HELSINKI, Finland, March 4, 2004 (PRIMEZONE) -- Proha Plc:
-- The Proha Group's net sales in 2003 were EUR 76.8 (100.8 in 2002)
million.
-- Decline in net sales compared with 2002 was...
Basilea beabsichtigt Börsenkotierung
March 04, 2004 01:30 ET
|
Basilea Pharmaceutica AG
Basel, Schweiz, 4 März 2004
Basilea Pharmaceutica AG ('Basilea') beabsichtigt, ihre Aktien an der Schweizer Börse SWX zu kotieren. Der Börsengang soll, abhängig von der Situation am...
Basilea To List On SWX (posted 2 June 2004)
March 04, 2004 01:30 ET
|
Basilea Pharmaceutica AG
Basel, Switzerland, 4 March 2004
Basilea Pharmaceutica AG ('Basilea') today announced its intention to list on the SWX Swiss Exchange through an initial public offering (IPO) expected to be...
Discovery Laboratories to Present at the SG Cowen 24th Annual Health Care Conference
March 03, 2004 20:03 ET
|
Discovery Laboratories, Inc.
DOYLESTOWN, Pa., March 3, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a biopharmaceutical company developing its proprietary surfactant technology as Surfactant Replacement...
- July 18, 2024 16:05 ET Thumzup to Support an Evening of Comedy and Community at LA School of Comedy
- July 18, 2024 15:20 ET GenFlat Holdings Welcomes Six New Advisory Committee Members